Characteristics of bronchoalveolar lavage fluid in patients with sulfur mustard gas-induced asthma or chronic bronchitis

American Journal of Medicine

Volumn 106, Issue 6, 1999, Pages 625-628

  Emad, Ali ^a   Rezaian, Gholam Reza ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

MUSTARD GAS;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL COMPOSITION; CHRONIC BRONCHITIS; DNA ALKYLATION; EPITHELIUM CELL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPIROMETRY; TISSUE INJURY;

ADULT; ASTHMA; BRONCHITIS; BRONCHOALVEOLAR LAVAGE FLUID; CARBON MONOXIDE; CASE-CONTROL STUDIES; CHEMICAL WARFARE AGENTS; CHRONIC DISEASE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULINS; MUSTARD GAS; SERUM ALBUMIN; VETERANS; VITAL CAPACITY;

EID: 0033040579     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00127-8     Document Type: Article

References (23)

1. Wormser U. Toxicology of mustard gas. Trends Pharmacol Sci. 12:1991;164-167.
2. Reports of specialists appointed by the Secretary General to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons. New York: Security Council of the United Nations document S/16433, 1986.
3. Calvet J.H., Jarreau P.H., Levame M., et al. Acute and chronic respiratory effects of sulfur mustard intoxication in guinea pig. J Appl Physiol. 76:1994;681-688.
4. Chevillard M., Lainee P., Robineau P., Puchelle E. Toxic effects of sulfur mustard on respiratory epithelial cells in culture. Cell Biol Toxicol. 8:1992;171-181.
5. Emad A., Rezaian G.R. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure analysis of 197 cases . Chest. 112:1997;734-738.
6. Case R.A.M., Lea A.J. Mustard gas poisoning, chronic bronchitis and lung cancer. Br J Prev Soc Med. 9:1955;62-68.
7. Winterniz W. Chronic lesions of the respiratory tract initiated by inhalation of irritant gases. JAMA. 73:1919;689.
8. Quackenboss J.J., Lebowitz M.D., Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates relationship to symptoms and respiratory diseases . Am Rev Respir Dis. 143:1991;323-330.
9. Clark T.J., Hetzel M.R. Diurnal variation of asthma. Br J Dis Chest. 71:1977;87-92.
10. Ries A.K. Response to bronchodilators. Clausen J.L. Pulmonary Function Testing Guidelines and Controversies . 1982;215-221 Academic Press, New York.
11. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 136:1987;225-244.
12. Delacroix D.L., Marchandise F., Francis C., Sibille Y. Alpha-2-macroglobulin, monomeric and polymeric immunoglobulins A, and immunoglobulin M in bronchoalveolar lavage. Am Rev Respir Dis. 132:1985;829-835.
13. Delacroix D.L., Hodgson H.J.F., McPherson A., Dive C., Vaerman J.P. Selective transport of polymeric immunoglobulin A in bile quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M and other proteins in serum, bile and saliva . J Clin Inves. 70:1982;230-241.
14. Ogilvie C.M., Forster R.E., Blakemore W.S., Morton J.W. A standardized breath holding technique for the clinical measurement of the diffusion capacity of the lung for carbon monoxide. J Clin Lab Inves. 36:1957;1-17.
15. Alberts W.M., do Pico G.A. Reactive airway dysfunction syndrome. Chest. 109:1996;1818-1826.
16. Reynolds H.Y. Bronchoalveolar lavage. Am Rev Respir Dis. 135:1987;250-263.
17. Emad A. Bronchoalveolar lavage a useful method for diagnosis of some pulmonary disorders . Respir Care. 42:1997;765-790.
18. Bensein I.L., Boushey H.A., Cherniack R.M. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatic patients. Chest. 88:1985;136-138.
19. Wardlaw A.J., Dunnette S., Gleich G.J., Collins J.V., Kay A.B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis. 137:1988;62-69.
20. Frew A.J., St-Pierre J., Teran L.M., et al. Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways. J Allergy Clin Immunol. 98:1996;133-143.
21. Teran L.M., Noso N., Carroll M., Davies D.E., Holgate S., Schroder I.M. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol. 157:1996;1806-1812.
22. Venge J., Lampinen P.I., Hakansson L., Rak S., Venge P. Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allerg Clin Immunol. 97:1996;1110-1115.
23. Thompson A.B., Daughton D., Robins R.A., Ghafouri M.A., Oehlerking M., Rennard S.I. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis. 140:1989;1527-1537.